HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 709-720 of 4,505
Other study type icon
Active Not RecruitingNCT05527210

Prebiotic Treatment in People With Schizophrenia

What is this study about?

This study assesses thinking abilities.

This study is no longer accepting new participants.

In Catonsville
SchizophreniaPlacebo comparisonAges 18–60
Countries
United States
Sponsor
University of Maryland, Baltimore
Drug study icon
CompletedNCT03617783

Prebiotic Treatment in People With Schizophrenia - Study

Official study title

Prebiotic Treatment in People With Schizophrenia

This study has finished and is no longer accepting participants.

In Catonsville
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
University of Maryland, Baltimore
Other study type icon
CompletedNCT00523783

Seroquel Long-Term NIS for Schizophrenia Patients

Official study title

24-Week Naturalistic Observational Study of Efficacy of Quetiapine in Patients With Schizophrenia or Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Seoul
SchizophreniaObservational studyAges 18–65
Countries
South Korea
Sponsor
AstraZeneca
Drug study icon
TerminatedNCT04986072

Sodium Nitroprusside in Early Course Schizophrenia

Official study title

Proof of Mechanism Study Using a Retinal Biomarker to Predict Treatment Response With Intravenous Sodium Nitroprusside in Symptomatic Early Course Schizophrenia

This study ended early.

In Boston
SchizophreniaMedication studyAges 18–40
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Drug study icon
CompletedNCT00406315

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

What is this study about?

This study evaluated the safety and effectiveness of ziprasidone for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
SchizophreniaMedication studyAges 18–55
Countries
United States, Brazil, Germany, + 3 others
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.